Antiplatelet Therapy and Cardiovascular Diseases

37 ta ish

1. Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures

   E. Shalaeva, Hugo Saner, B. Janabaev +1

   MaqolaAntiplatelet Therapy and Cardiovascular DiseasesEuropean Journal of Preventive Cardiology20173 iqtibos

   ABIABI:AkademIndex/2026.other.134863

2. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms

   Jamol Uzokov, B. A. Alyavi

   MaqolaAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20202 iqtibos

   ABIABI:AkademIndex/2020.article.001189

3. Aspirin Resistance in Patients with Chronic Coronary Syndrome

   A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1

   MaqolaOAOchiq kirishAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology20212 iqtibos

   ABIABI:AkademIndex/2021.article.002392

4. Relationship between blood inflammation state and platelet aggregation rate in patients with atherosclerotic coronary artery disease after percutaneous coronary interventions

   Jamol Uzokov, Bakhromkhon Alyavi, B. Karimov +1

   MaqolaOAOchiq kirishInflammatory Biomarkers in Disease PrognosisAtherosclerosis20231 iqtibos

   ABIABI:AkademIndex/2023.article.003955

5. Polyelectrolyte Microcapsules—A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release

   Aleksandr L. Kim, Egor V. Musin, M. Zh. Oripova +3

   MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesInternational Journal of Molecular Sciences20231 iqtibos

   ABIABI:AkademIndex/2026.other.317658

6. QANDLI DIABET KASALLIGI FONIDA YURAK QON TOMIR TIZIMI KASALLIKLARINING KLINIK KECHUV XUSUSIYATLARI

   Исламова Камола Акрамовна, Карабаева Гульчехра Худойбердиевна

   MaqolaDiabetes, Cardiovascular Risks, and Lipoproteins20201 iqtibos

   ABIABI:AkademIndex/2026.other.721580

7. Resveratrol Inhibits Platelet Aggregation in Aspirin Resistance

   Gyorgyi Stef, Kenneth M. Lerea, Joseph Wu +2

   MaqolaAntiplatelet Therapy and Cardiovascular DiseasesThe FASEB Journal20060 iqtibos

   ABIABI:AkademIndex/2006.article.000452

8. Polysthicol

   Shakhnoza S. Azimova

   BobCase Reports on Hematomas20120 iqtibos

   ABIABI:AkademIndex/2012.chapter.001929

9. Methylquadrangularate C

   Shakhnoza S. Azimova

   BobCancer Treatment and Pharmacology20120 iqtibos

   ABIABI:AkademIndex/2012.chapter.005073

10. Influence of Lipid Transport System Gene Polymorphism on the Dyslipidemia and Coronary Lesions in Patients with Unstable Angina

    A. S. Eshpulatov, Tashkent, Uzbekistan, Shavkat Hashimov +2

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine20150 iqtibos

    ABIABI:AkademIndex/2015.article.000792

11. One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent

    Nabijon Yuldashev, Robert Gil, R. D. Kurbanov

    MaqolaOAOchiq kirishCoronary Interventions and DiagnosticsInternational Journal of Biomedicine20180 iqtibos

    ABIABI:AkademIndex/2018.article.000491

12. PO149 Compliance of Patients With Coronary Artery Disease In Correlation With Clinical and Angiographic Data

    G. Nagaeva, N. Juldashev, S. Nagaev

    MaqolaPeripheral Artery Disease ManagementGlobal Heart20180 iqtibos

    ABIABI:AkademIndex/2018.article.000880

13. Prevalence and Features of Aspirin Resistance in Patients with Coronary Artery Disease

    Khodjanova SH

    MaqolaOAOchiq kirishAntiplatelet Therapy and Cardiovascular DiseasesCross Current International Journal of Medical and Biosciences20200 iqtibos

    ABIABI:AkademIndex/2020.article.005217

14. Evaluations of Hemostatic Activity of Ethanol Extract of Euonymus fortunei Aerial Parts

    Xi‐Lin Ouyang, Lin-Yan Shu, Xiaoya Qin +1

    MaqolaOAOchiq kirishPlatelet Disorders and TreatmentsJournal of Pharmaceutical Research International20210 iqtibos

    ABIABI:AkademIndex/2021.article.000911

15. Antiplatelet therapy with clopidogrel taking into account CYP2C19 genetic polymorphisms in patients with coronary heart disease after coronary artery stenting

    Jamol Uzokov, B. A. Alyavi, A. Abdullaev +2

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20210 iqtibos

    ABIABI:AkademIndex/2021.article.008297

16. ANTIPLATELET THERAPY AND SECONDARY PROPHYLAXIS AFTER CORONARY BYPASS SURGERY IN ACUTE CORONARY SYNDROME

    Jalilov A.K., Isadora Almeida G

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesMedical & pharmaceutical journal Pulse20210 iqtibos

    ABIABI:AkademIndex/2021.article.008457

17. The value of the Left Ventricular Emission Fraction in Patients with Ischaemic Heart Disease with Diabetes Mellitus 2 in the Assessment of the Effectiveness of Sitagliptin/Metformin

    Раиса Тригулова, Dilnoza Alimova, N.F. Tashkenbaeva +4

    MaqolaDiabetes Treatment and ManagementAmerican Heart Journal20210 iqtibos

    ABIABI:AkademIndex/2021.article.009215

18. YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA ATSETILSALITSIL KISLOTANING ANTIAGREGANT VA YALLIG'LANISHGA QARSHI XUSUSIYATLARI

    Шахноза Искандаровна Ходжанова

    MaqolaAntiplatelet Therapy and Cardiovascular Diseases20210 iqtibos

    ABIABI:AkademIndex/2021.article.013019

19. Advantages of aspirin in the prevention of cardiovascular disease

    M Niladri, Gayatri Devi, Prateek Porwal +4

    MaqolaOAOchiq kirishInflammatory mediators and NSAID effectsInternational Journal of Health Sciences20220 iqtibos

    ABIABI:AkademIndex/2022.article.005434

20. Polymorphism in the apolipoprotein C3 gene and coronary lesions in patients with CHD

    Р Алиева, A. Eshpulatov, Aleksandr B. Shek

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20220 iqtibos

    ABIABI:AkademIndex/2022.article.007489

21. Clopidogrel efficacy after percutaneous coronary interventions considering with CYP2C19 genetic polymorphisms in patients with coronary heart disease

    Jamol Uzokov, B. Alyavi, A. Kh. Abdullaev +2

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20220 iqtibos

    ABIABI:AkademIndex/2022.article.007497

22. #4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD

    Yorkin Rasulev, Durdona Adylova

    MaqolaOAOchiq kirishPeripheral Artery Disease ManagementNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/2023.article.001882

23. Ticagrelor in the treatment of patients with acute coronary syndrome: own clinical experience

    Н Юлдошев, Г. А. Нагаева, М. Ж. Журалиев +3

    MaqolaOAOchiq kirishAntiplatelet Therapy and Cardiovascular DiseasesThe Bulletin of Emergency Medicine20230 iqtibos

    ABIABI:AkademIndex/2023.article.003207

24. Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions

    M Mukhamedova, D Z Orziev, Jamol Uzokov +1

    MaqolaOAOchiq kirishAntiplatelet Therapy and Cardiovascular DiseasesEuropean Journal of Cardiovascular Nursing20230 iqtibos

    ABIABI:AkademIndex/2023.article.003884

25. CHANGES IN THE LEVEL OF C-REACTIVE PROTEIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHILE TAKING COLCHICINE

    Agababyan Irina Rubenovna, KOBILOVA Nigina Akmalovna

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthZenodo (CERN European Organization for Nuclear Research)20230 iqtibos

    ABIABI:AkademIndex/2023.article.009920